The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
CTI BioPharma Corp(NASDAQ:CTIC) 
CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It develops pacritinib, an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CS...
Website: http://www.ctibiopharma.com
Full Time Employees: 25
Sector: Healthcare
Industry: Biotechnology
CTI BioPharma Corp Days Payable Outstanding ttm (DPO)
CTI BioPharma Corp Days Receivable Outstanding ttm (DSO)
CTI BioPharma Corp Days Inventory Outstanding ttm (DIO)
CTI BioPharma Corp Op Cashflow Per Share ttm
CTI BioPharma Corp Free Cashflow Per Share ttm
CTI BioPharma Corp Cash Per Share ttm
CTI BioPharma Corp P/S ratio ttm
CTI BioPharma Corp (GAAP) P/E ratio ttm
CTI BioPharma Corp P/B ratio ttm
No extra charts and metrics for this ticker.